66 related articles for article (PubMed ID: 15487919)
1. [In vitro susceptibility of dematiaceous fungi to ten antifungal drugs using an agar diffusion test].
Cermeño-Vivas JR; Torresrodríguez JM
Rev Iberoam Micol; 2001 Sep; 18(3):113-7. PubMed ID: 15487919
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Vivas JR; Torres-Rodríguez JM
Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
[TBL] [Abstract][Full Text] [Related]
3. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].
Carrillo-Muñoz AJ; Santos P; del Valle O; Casals JB; Quindós G
Rev Esp Quimioter; 2004 Sep; 17(3):244-9. PubMed ID: 15619653
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method.
Skóra M; Macura AB
Wiad Parazytol; 2011; 57(2):111-6. PubMed ID: 21682097
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
Buchta V; Navrátilová L; Förstl M; Kubanová P
Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
[TBL] [Abstract][Full Text] [Related]
6. [In vitro resistance to fluconazole and itraconazole in clinical isolates of Candida spp and Cryptococcus neoformans].
Carrillo Muñoz AJ; Tur C; Estivill D; Montsant L; Carceller A; Hernández-Molina JM; Torres Rodríguez JM
Rev Iberoam Micol; 1997 Jun; 14(2):50-4. PubMed ID: 16854170
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
Karaca N; Koç AN
Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
[TBL] [Abstract][Full Text] [Related]
8. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing.
Carrillo-Muñoz AJ; Abarca L; Quindós G; Arévalo P; Bornay F; Cabañes FJ; Casals JB; Estivill D; Gonzalez-Lama Z; Iglesias I; Hernández-Molina JM; Linares MJ; Martín-Mazuelos E; Payá MJ; Pereiro M; San Millán R; Rubio MC
Rev Iberoam Micol; 1999 Jun; 16(2):92-6. PubMed ID: 18473576
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility testing method for resource constrained laboratories.
Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of five antifungal agents against pathogenic Exophiala species.
Li D; Li R; Wang D; Ma S
Chin Med J (Engl); 1999 Jun; 112(6):484-8. PubMed ID: 11601322
[TBL] [Abstract][Full Text] [Related]
14. [Study of the susceptibility of black yeasts of the Exophiala genus to antifungals using the Sensititre System].
Puerto JL; García-Martos P; Marín P; Sepúlveda A; García-Agudo R; Aoufi S
Rev Esp Quimioter; 2002 Sep; 15(3):268-71. PubMed ID: 12582431
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
Trancassini M; Ghezzi MC; Cipriani P; Mancini C; Brenciaglia MI
Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B.
Daboit TC; Massotti Magagnin C; Heidrich D; Czekster Antochevis L; Vigolo S; Collares Meirelles L; Alves K; Scroferneker ML
Mycoses; 2014 Feb; 57(2):116-20. PubMed ID: 23895037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
